Hades Pharma Private Limited
About Hades Pharma Private Limited
Data last updated:
Hades Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33300DL2017PTC316019. Its GSTIN is 06AAECH1628J1ZO (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Tanu Bindra and Sapaksh Rohaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 16/9 Kishan Garh Vasant Kunj, New Delhi, Delhi, India – 110070.
As per the financials filed for FY 2023, the company reported a revenue of ₹6.72 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹37,178 (net margin -5.5%) and EBITDA of -₹35,678 (EBITDA margin -5.3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hades Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 16/9 Kishan Garh Vasant Kunj, New Delhi, Delhi, India – 110070
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hades Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hades Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Hades Pharma Private Limited, buy the company report.
Financials of Hades Pharma Private Limited
FY 2025 filings availableHades Pharma Private Limited reported revenue of ₹6.72 Lakh (up 10714% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹6.72 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹35,678 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹37,178 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.3% | ||||
| Net Profit Margin | -5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hades Pharma Private Limited, buy the company report.
Board of directors of Hades Pharma Private Limited
Hades Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rosy Also directs: Chubby Cheeks Creations LLP, Viknit Ecom Private Limited | Additional Director | 29 Sep 2025 | 1 Years 0 Months | Current |
| Tanu Bindra | Director | 12 Apr 2017 | 9 Years 6 Months | Current |
| Sapaksh Rohaj | Director | 12 Apr 2017 | 9 Years 6 Months | Current |
Auditor
Hades Pharma Private Limited is audited by MONIKA TYAGI & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MONIKA TYAGI & COMPANY | FY 2023 | 024752N |
Shareholding
The shareholding of Hades Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hades Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hades Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hades Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hades Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECH1628J1ZO | Haryana | Active | 02 Jan 2018 |
To see the full GST registrations and return filing status of Hades Pharma Private Limited, buy the company report.
Recent activity
Hades Pharma Private Limited has 5 board changes on record since 2017: 4 appointments and 1 cessation. The latest: Rosy was appointed as Additional Director on 29 Sep 2025.
Frequently asked questions
Hades Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 April 2017 (9+ years old) and is registered under CIN U33300DL2017PTC316019.
Hades Pharma has 3 current directors:
- Rosy - Additional Director
- Tanu Bindra - Director
- Sapaksh Rohaj - Director
The latest financial statements of Hades Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Hades Pharma is 06AAECH1628J1ZO, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Hades Pharma is U33300DL2017PTC316019. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hades Pharma was incorporated on 12 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Rosy was appointed as Additional Director on 29 Sep 2025. Vipin Bindra ceased to be Director on 29 Sep 2025. Sapaksh Rohaj was appointed as Director on 12 Apr 2017. Hades Pharma has 5 board changes on record in total.
The registered office of Hades Pharma is at House No. 169 Kishan Garh Vasant Kunj, New Delhi, Delhi, India – 110070.
Hades Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Hades Pharma is compliant as of 12 August 2026. The company is actively filing with the Registrar of Companies.